No Data
No Data
Aerovate Therapeutics Reports Q3 Loss Amid Strategic Shift
Aerovate | 10-Q: Q3 2024 Earnings Report
Calendar of U.S. Earnings Expected in the Week Ahead
M&A Deals Roundup: AbbVie, Blackstone, Take-Two Interactive and More
12 Health Care Stocks Moving In Thursday's Intraday Session
Express News | Aerovate Therapeutics - Upon Termination of Deal Under Specified Circumstances, Co May Be Required to Pay Jade Termination Fee of $2.3 Mln
103892611 : yes
WeiTheSaint469 OP : thank God I got out lol